STOCK TITAN

Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability

(Positive)
Tags

Marpai (OTCQX:MRAI) announced multiple new client wins across its core TPA and MarpaiRx PBM divisions, spanning diverse self-insured employer groups. These contracts are expected to expand the member base and be key drivers toward profitability and positive operating cash flow.

The agreements include comprehensive TPA, integrated pharmacy benefit management, and coordinated healthcare solutions that combine medical optimization, cost containment, and proactive member services, supporting Marpai’s data-driven, transparency-focused healthcare offering.

Loading...
Loading translation...

Positive

  • New TPA and MarpaiRx client contracts across diverse self-insured employer groups
  • Expected member base expansion supporting path to profitability and positive operating cash flow
  • Integrated TPA and PBM offerings aimed at cost containment and better clinical outcomes
  • Strategic collaborations cited as providing a substantial growth pipeline

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

TAMPA, Fla., May 11, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit Management ("PBM") services, today announced several significant new business wins across its core TPA and MarpaiRx divisions. These new client wins, representing a diverse range of self-insured employer groups, are expected to be primary drivers in the Company's path toward achieving sustained profitability.

Pursuant to the newly secured contracts, Marpai is expected to provide comprehensive TPA services and integrated pharmacy benefit management services through MarpaiRx, reflect the growing demand for Marpai's data driven health plan management and its commitment to radical transparency in drug spend.

Strategic Impact and Growth: The expected expansion of the Company's member base through these wins directly supports Marpai's objective of reaching profitability and positive operating cash flow. By integrating TPA and PBM services, Marpai continues to deliver a high-performance healthcare offering designed to reduce the cost of care for our clients while improving clinical outcomes for members.

Key highlights of the new business wins include:

  • TPA Expansion: New domestic employer groups transitioning to Marpai's data-driven administration platform.
  • MarpaiRx Acceleration: Increased adoption of our framework, providing members with competitive pricing and rebate transparency.
  • Integrated Solutions: A significant portion of the new contracts include coordinated healthcare solutions that combine medical optimization, proven cost containment with proactive member services.

Leadership Perspectives: "We believe these wins, among the most significant in our Company's history, directly validate the strength of Marpai's value proposition and reflect the immediate impact of the strategic agreements we announced earlier this year," said Damien Lamendola, Chief Executive Officer of Marpai. "Our strategic collaborations have provided us with a substantial pipeline to accelerate growth and move us closer to our goal of positive operating cash flow and profitability. By leveraging MarpaiRx and our data-driven TPA capabilities through this expanded market reach, we believe that we are delivering a unique, integrated healthcare offering that serves the best interests of plan sponsors and their members."

About Marpai, Inc. Marpai, Inc. (OTCQX: MRAI) is a technology platform company which operates subsidiaries that provide TPA, PBM and value-oriented health plan services to employers that directly pay for employee health benefits. Marpai works to deliver the healthiest member population for the health plan budget through its Marpai Saves initiative. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna. For more information, visit www.marpaihealth.com, the content of which is not incorporated by reference into this press release. Investors are invited to visit https://ir.marpaihealth.com.

Forward-Looking Statement Disclaimer

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "guidance," "may," "can," "could", "will", "potential", "should," "goal" and variations of these words or similar expressions. For example, the Company is using forward-looking statements when it discusses the new contracts as the primary drivers in the Company's path towards achieving sustained profitability in 2026, the benefits of its TPA services and products, that the contracts move it closer to its goal of positive operating cash flow and profitability, and its belief that it is delivering a unique, integrated healthcare offering that serves the best interests of plan sponsors and their members. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai's current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.

More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.

(PRNewsfoto/Marpai)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/marpai-inc-announces-significant-new-business-wins-across-tpa-and-marpairx-solidifies-forecast-for-profitability-302768280.html

SOURCE Marpai

FAQ

What new business wins did Marpai (OTCQX:MRAI) announce on May 11, 2026?

Marpai announced several new client wins across its TPA and MarpaiRx divisions. According to Marpai, these contracts with diverse self-insured employer groups will expand its member base and support progress toward profitability and positive operating cash flow.

How do the new TPA contracts impact Marpai’s path to profitability (MRAI)?

The new TPA contracts are expected to expand Marpai’s member base and drive operating leverage. According to Marpai, this expansion directly supports its objective of achieving sustained profitability and positive operating cash flow through data-driven health plan administration.

What role does MarpaiRx play in Marpai’s new business wins and profitability goals?

MarpaiRx provides integrated pharmacy benefit management in many of the new contracts. According to Marpai, increased MarpaiRx adoption, competitive pricing, and rebate transparency are important elements in its strategy to reduce client healthcare costs and support the move toward profitability.

What integrated healthcare solutions are included in Marpai’s latest contracts (MRAI)?

A significant portion of the new contracts include coordinated medical and pharmacy solutions. According to Marpai, these combine medical optimization, proven cost containment programs, and proactive member services to improve clinical outcomes while managing overall healthcare spending for plan sponsors.

How do Marpai’s strategic collaborations support its growth and cash flow objectives?

Marpai links these new wins to strategic collaborations formed earlier in the year. According to Marpai, these partnerships created a substantial pipeline that is expected to accelerate growth and move the company closer to positive operating cash flow and sustained profitability.

Why does Marpai emphasize data-driven administration and transparency in its TPA and PBM services?

Marpai’s platform focuses on data-driven decision-making and radical transparency in drug spending. According to Marpai, integrating analytics with TPA and PBM services is designed to reduce healthcare costs for employer clients while improving clinical outcomes for covered members.